Michael Brooks

Chief Operating Officer
  • Oversees seamless connections and day-to-day operations across Clinical Development, Medical Affairs and Commercial Solutions businesses, with a focus on creating greater customer success through integrated solutions and technology-driven insights
  • Most recently served as Syneos Health’s Chief Development Officer & Global Head of Clinical Development Solutions, encompassing clinical pharmacology services, full service clinical trial and product development capabilities, scientific and therapeutic expertise, FSP and hybrid models, and digital and mobile health solutions
  • 25+ years of clinical development and commercialization experience; strong track record of transforming business units and companies, setting strategy and spearheading high-value solutions across the product development lifecycle; and a passionate focus on unifying teams toward a singular objective and helping colleagues across the globe achieve their career goals
  • Brings extensive global product development experience to Syneos Health from prior roles, including serving as President & Global Head of Clinical Development & Commercialization Services at LabCorp (Covance) and Executive Vice President & Global Head of Clinical Development at PRA Health Sciences including work across phase I-IV, FSP, clinical pharmacology/phase I units, real-world outcomes/post marketing, consulting, commercial services and global service delivery hubs in China and India
  • Bachelor of Science, North Carolina State University; Member, College of Sciences Foundation; Board of Directors, North Carolina State University